Case Report - (2014) Volume 5, Issue 3
Although the latest trials (DESTINY, DESTINY II, HAMLET, DECIMAL) have provided evidence that
decompressive hemicraniectomy in malignant MCA infarction (MMI) can improve survival rates and neurological
outcomes, the decision for or against the procedure remains challenging in respect of the inclusion and exclusion
criteria, such as the definition of MMI, severity of symptoms at stroke onset and neuroimaging findings.
This report focuses on a young patient who suffered an MMI of the right hemisphere. Because of a rapid
deterioration in the clinical symptoms, we decided to perform an early decompressive hemicraniectomy after 24h.
The patient survived without any complications, and with a favourable outcome (mRS 1).
The case shows that young patients in particular can have a remarkable potential for full recovery after an MMI,
and that the benefits of surgery outweigh the risks, provided that 1) the hemicraniectomy is performed promptly
(after careful consideration of whether brain swelling might occur soon after MMI), and 2) the elective brain territories
have not yet been affected.
Keywords: Malignant MCA infarction (MMI); Brain edema; Hemicraniectomy; NIHSS
The term malignant MCA infarction (MMI) was first used in 1996, however, there is still no generally accepted definition for this term, with the major studies to date having chosen clinical criteria to describe this condition, i.e. the severity of neurological symptoms at stroke onset (NIHSS = National Institute for Health Stroke Scale), rapid deterioration in symptoms, and neuroimaging findings [1-6].
As yet, life threatening edema has been ruled out if at least two thirds of the MCA vascular territory or more than 50% of the MCA vascular territory are affected, or more than 82ml on a DWI (diffusion weighted image) MRI sequence within the first 6h after stroke onset, or more than 145ml on DWI sequence within the first 14h after stroke onset are affected [7-9].
Besides the DESTINY trial, no other study has exclusively mentioned brain territories that have been affected by stroke, with DESTINY including those patients whose basal ganglia were at least partially affected [4].
As it seems somewhat challenging to arrive at a true definition of +MMI based on the early onset of clinical symptoms, it might prove valuable to consider not only the vascular territories, but also the elective brain territories, in order to define an MMI in which life threatening edema occurs. A precise evaluation of the affected brain territories might also be important to estimate the outcome of the modified Rankin scale after rehabilitation of the individual patient.
We report the case of a 44 year old patient who suffered a repeated middle artery infarction of the right hemisphere in May 2011. The patient was admitted to our stroke unit due to a rapidly recurring left-sided brachio-facial hemiparesis, which was accompanied by a severe headache but no loss of consciousness. The NIHSS at stroke onset was 10 points.
The first CCT scan showed a right-hemispheric middle artery infarction within the frontal region (Figure 1) as well as an old left hemispheric infarction (but without any remaining neurological symptoms). As a result of the exacerbation of symptoms within one day, and with severe left-sided hemiparesis accompanied by a total neglect of the left side, a second CCT scan was performed. The NIHSS at this stage was 18 points.
Figure 1: First CCT scan, acquired after the first stroke
The CCT scan revealed a second widespread cerebral artery infarction with more than two-thirds of the vascular MCA territory affected (Figure 2). There was also a slight compression of the right ventricle, but no midline shift, while the basal ganglia of the right hemisphere did not seem to be affected (Figure 2). The patient soon developed acute clinical symptoms of brain pressure (drowsiness, slow light reaction of the pupils, increased hemiparesis); thus, we decided to perform an early decompressive hemicraniectomy due to a suspected MMI (Figure 3A, 3B: after re-implantation of the right cranium).
Figure 2: Second CCT scan, acquired after the second stroke, showing the beginning of oedema of the right hemisphere.
Figure 3: (A) 3 days after hemicraniectomy. (B) 3 months after hemicraniectomy, after reimplantation of the right cranium.
The post-surgery monitoring revealed the presence of paroxysmal atrial fibrillation, which was the likely cause of the (bi-) hemispheric strokes. We treated the patient with systemic anti-coagulation using heparin (increasing the starting PTT two to three times), and later with oral dabigatran (150mg twice daily). Three days after surgery, we transferred the patient to our early rehabilitation program. Subsequently, the patient was transferred to a neurological rehabilitation clinic for several months (when he left our clinic the NIHSS score was 4 and the mRS score was 2), and continued later with physiotherapy and ergotherapy. Despite the presence of sensory deficiency on the left side, no neurological symptoms were obvious. The patient was able to participate actively in all daily activities, and returned to his workplace eight months after the stroke. Our patient is an outstanding example of a near complete recovery after an MMI10 by early hemicraniectomy.
Concerning the DESTINY trial, our patient is unlikely to have been recommended for hemicraniectomy because the basal ganglia were not affected, the NIHSS score at symptom onset was only 10 points, and he had previously suffered from a small frontal left hemispheric infarction, although without any neurological symptoms remaining (Figures 1-3). Nevertheless, we considered the stroke in this case as an MMI, given the vascular territory affected, the poor NIHSS score and the rapid deterioration in clinical symptoms over a 24h period.
Due to the probability that the basal ganglia might be affected by severe brain swelling without an early hemicraniectomy, the concerning mRS result and the worsening of the clinical symptoms, we decided to perform early surgery. A further point influencing our decision for surgery was the age of our patient. The aforementioned trials [2,4,6], excluding DESTINY II [3], all included patients between the ages of 18 and 60, or up to 55 years (DECIMAL [6]); the DESTINY II trial included patients older than 61 years [3].
The final results of the DESTINY II study now confirm that decompressive hemicraniectomy increased survival without severe disability among patients 61 years of age or older and with brain swelling after a malignant middle-cerebral-artery stroke. Therefore, elderly patients have a similar potential for favorable outcome, considered as mRS < 4 or 3, as per the younger patients. Nevertheless, approving this procedure remains an individual decision that depends on the biological age, the patient’s presumable will to survive in a more challenging post-operative condition, and any secondary life-threatening diseases.
The required NIHSS at symptom onset was a further point of consideration, which should be higher than 14 out of 42 points for both hemispheres. Our patient initially had an NIHSS score of 10, and then after the deterioration of symptoms we scored the NIHSS with 18 points. The DECIMAL trial set a high NIHSS score of at least 16 points for both hemispheres, while the HAMLET, DESTINY and DESTINY II trials also differed between the left (dominant) and right (non-dominant) hemispheres [2-4].
The following results of our clinical considerations confirm our decision for hemicraniectomy: first, young patients have a remarkable potential for full recovery after an MMI [10]; second, if the basal ganglia are not affected by the stroke, the overall expected outcome (mRS) might be more favorable; and third, the benefits of an (early) hemicraniectomy (within the first 48h), performed after careful consideration of whether brain swelling might occur soon after MMI, outweigh the risk of surgery in young patients [11-15].
Therefore, clinicians should be aware of the potential for performing early hemicraniectomy in patients in good health but with severe brain damage, in order to prevent the symptoms of brain swelling and additional brain damage resulting from swelling.
